These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3861246)

  • 21. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome abnormalities in leukemia and lymphoma.
    Rowley JD
    Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chromosome abnormalities in leukemia in children. Occurrence and clinical significance].
    Hählen K; Hagemeijer A
    Tijdschr Kindergeneeskd; 1982 Dec; 50(6):198-203. PubMed ID: 6963036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and release of platelet-activating factor (PAF) from enriched preparations of rabbit basophils; failure of human basophils to release PAF.
    Betz SJ; Lotner GZ; Henson PM
    J Immunol; 1980 Dec; 125(6):2749-55. PubMed ID: 6159420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization of labile glucocorticoid-receptor complexes from acute nonlymphocytic leukemia cells by a factor from chronic lymphocytic leukemia cells.
    Holbrook NJ; Bloomfield CD; Munck A
    Cancer Res; 1984 Jan; 44(1):407-14. PubMed ID: 6690056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of glycolipids in various human leukemia cells.
    Kyogashima M; Uemura K; Taketomi T
    Jpn J Cancer Res; 1987 Nov; 78(11):1229-37. PubMed ID: 3121559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biphenotypic and bilineal acute leukemias].
    Batinić D; Dubravcić K; Rajić L; Mikulić M; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):387-90. PubMed ID: 19209464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet function in chronic leukemias.
    Naresh KN; Sivasankaran P; Veliath AJ
    Indian J Cancer; 1992 Jun; 29(2):49-55. PubMed ID: 1473832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the Technicon H-1 in the characterization of leukemias.
    Krause JR; Costello RT; Krause J; Penchansky L
    Arch Pathol Lab Med; 1988 Sep; 112(9):889-94. PubMed ID: 3166371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL).
    Bene MC; Bernier M; Casasnovas RO; Castoldi G; Knapp W; Lanza F; Ludwig WD; Matutes E; Orfao A; Sperling C; van't Veer MB
    Blood; 1998 Jul; 92(2):596-9. PubMed ID: 9657760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.
    Pinckard RN; Farr RS; Hanahan DJ
    J Immunol; 1979 Oct; 123(4):1847-57. PubMed ID: 479602
    [No Abstract]   [Full Text] [Related]  

  • 38. Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation.
    Camussi G; Bussolino F; Ghezzo F; Pegoraro L
    Blood; 1982 Jan; 59(1):16-22. PubMed ID: 6947829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies.
    Camussi G; Niesen N; Tetta C; Saunders RN; Milgrom F
    Transplantation; 1987 Jul; 44(1):113-8. PubMed ID: 3299910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of platelet-activating factor in human plasma. Application to patients with liver cirrhosis and disseminated intravascular coagulation.
    Sugatani J; Miwa M; Komiyama Y; Murakami T
    J Immunol Methods; 1993 Dec; 166(2):251-61. PubMed ID: 8288878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.